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Abstract. 
 
E-cadherin is a tumor suppressor protein
with a well-established role in cell–cell adhesion. Adhe-
sion could contribute to tumor suppression either by
physically joining cells or by facilitating other juxtacrine
signaling events. Alternatively, E-cadherin tumor sup-
pressor activity could result from binding and antago-
 
nizing the nuclear signaling function of 
 
 
 
-catenin, a
known proto-oncogene. To distinguish between an ad-
hesion- versus a 
 
 
 
-catenin signaling–dependent mecha-
nism, chimeric cadherin constructs were expressed in
the SW480 colorectal tumor cell line. Expression of
wild-type E-cadherin signiﬁcantly inhibits the growth of
this cell line. Growth inhibitory activity is retained by all
constructs that have the 
 
 
 
-catenin binding region of the
cytoplasmic domain but not by E-cadherin constructs
 
that exhibit adhesive activity, but lack the 
 
 
 
-catenin
binding region. This growth suppression correlates with a
reduction in 
 
 
 
-catenin/T cell factor (TCF) reporter gene
activity. Importantly, direct inhibition of 
 
 
 
-catenin/TCF
signaling inhibits the growth of SW480 cells, and the
growth inhibitory activity of E-cadherin is rescued by
constitutively activated forms of TCF. Thus, the growth
suppressor activity of E-cadherin is adhesion indepen-
dent and results from an inhibition of the 
 
 
 
-catenin/TCF
signaling pathway, suggesting that loss of E-cadherin ex-
 
pression can contribute to upregulation of this pathway
in human cancers. E-cadherin–mediated growth sup-
pression was not accompanied by overall depletion of
 
 
 
-catenin from the cytosol and nucleus. This appears to be
 
due to the existence of a large pool of cytosolic 
 
 
 
-cate-
nin in SW480 cells that is refractory to both cadherin
binding and TCF binding. Thus, a small pool of 
 
 
 
-cate-
nin that can bind TCF (i.e., the transcriptionally active
pool) can be selectively depleted by E-cadherin expres-
sion. The existence of functionally distinct pools of cy-
tosolic 
 
 
 
-catenin suggests that there are mechanisms to
regulate 
 
 
 
-catenin signaling in addition to controlling
its level of accumulation.
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Introduction
 
E-cadherin is a calcium-dependent cell–cell adhesion mol-
ecule responsible for the major cell adhesion system in ep-
ithelia (Takeichi, 1995). Loss of E-cadherin expression or
mutations in the E-cadherin gene have been found to be
associated with several epithelial cancers and metastases
(Birchmeier and Behrens, 1994). Indeed, E-cadherin has
been identified as a bona fide tumor suppressor gene for
diffuse gastric carcinomas, and loss of E-cadherin expres-
sion has been shown to play a causal role in tumor pro-
gression using a transgenic mouse model (Perl et al., 1998).
Several different functions of E-cadherin could account
for its tumor suppressor activity, but the molecular mecha-
nism of tumor suppression has not yet been clearly estab-
lished for any particular type of tumor.
E-cadherin is a transmembrane protein with an extracel-
lular domain that mediates Ca
 
2
 
 
 
-dependent homophilic
binding and a cytoplasmic domain that interacts with the
catenin polypeptides 
 
  
 
and
 
  
 
 (or plakoglobin) and p120
 
ctn
 
.
This multiprotein complex interacts with the actin cyto-
skeleton and physically links cells to each other (for review
see Gottardi et al., 2001). Beyond forming the actual struc-
ture that joins neighboring cells, cadherin-mediated adhe-
sion initiates formation and organization of functionally
distinct cell junctions, such as tight and gap junctions, and
desmosomes (Gumbiner et al., 1988; Musil et al., 1990;
Watabe et al., 1994) and can facilitate juxtacrine or short
range signaling, which depends on the close apposition of
cells (for review see Fagotto and Gumbiner, 1996).
Although 
 
 
 
-catenin is a critical component of the cad-
herin cell adhesion complex, it also has a well-established
role as an essential mediator of the Wnt signal transduc-
tion pathway. Wnt/
 
 
 
-catenin signaling mediates many in-
 
Address correspondence to Barry M. Gumbiner, 1275 York Ave., Box
 
564, New York, NY 10021. Tel.: (212) 639-6147. Fax: (212) 717-3047. E-mail:
b-gumbiner@ski.mskcc.org 
The Journal of Cell Biology, Volume 153, 2001 1050
 
ductive events in development, and upregulation of this
pathway also plays a role in tumorigenesis (Wodarz and
Nusse, 1998). In the final step in this pathway, 
 
 
 
-catenin
interacts with lymphocyte enhancer factor (LEF)
 
1
 
/T cell
factor (TCF)–type transcription factors and activates tran-
scription by providing a transactivation domain (Behrens
et al., 1996; Molenaar et al., 1996; van de Wetering et al.,
1997; Hsu et al., 1998). The levels and activity of the sig-
naling competent pool of 
 
 
 
-catenin in the cytosol and nu-
cleus is controlled by a complex of proteins that includes
the adenomatous polyposis coli (APC) tumor suppressor
gene product, axin, glycogen synthase kinase-3, and other
polypeptides (Korinek et al., 1997; Behrens et al., 1998;
Hart et al., 1998; Morin et al., 1997; for review see Seiden-
sticker and Behrens, 2000). Constitutive upregulation of
 
 
 
-catenin levels and concomitant signaling, arising from
either loss-of-function mutations in APC or axin or acti-
vating mutations in 
 
 
 
-catenin, has been implicated in
many human cancers.
The fact that 
 
 
 
-catenin has two different functions, nu-
clear signaling and cadherin-mediated adhesion at the
plasma membrane, raises the interesting possibility that
cadherins could transduce a signal to the nucleus via 
 
 
 
-cat-
enin. Changes in cell–cell adhesion have not yet been
found to alter 
 
 
 
-catenin signaling or its translocation to
the nucleus. However, several studies have shown that
over-expression of cadherins in model systems can antago-
nize 
 
 
 
-catenin signaling by binding and sequestering it
from the nuclear signaling pool (Heasman et al., 1994;
Fagotto et al., 1996; Sanson et al., 1996). Conversely, ex-
perimental reduction of cadherin levels in 
 
Drosophila
 
 can
lead to enhanced 
 
 
 
-catenin (armadillo) signaling activity
(Cox et al., 1996). It is not yet known whether naturally oc-
curring changes in cadherin expression or function affect
 
 
 
-catenin nuclear signaling during normal development or
tumor progression.
Elucidating the mechanism of tumor suppression by E-cad-
herin is complicated by the fact that E-cadherin has been
implicated in both early and late stages of tumor progres-
sion. Initially it was thought that E-cadherin suppresses
tumor progression by inhibiting local invasion and me-
tastasis through increasing cell–cell adhesion because E-cad-
herin loss correlated with tumor invasiveness (Mareel
et al., 1993; Takeichi, 1993), and reintroduction of E-cad-
herin into invasive cell lines significantly reduced their in-
vasive properties (Frixen et al., 1991; Vleminckx et al.,
1991). However, 
 
 
 
-catenin can also regulate genes and
processes that influence invasive behavior, such as fibro-
nectin, matrilysin, or the epithelial–mesenchymal transi-
tion (Crawford et al., 1999; Gradl et al., 1999). More re-
cent studies have revealed that E-cadherin loss may also
contribute to early initiation stages of tumorigenesis. So-
matic mutations of the E-cadherin gene have been de-
tected in early noninvasive stages of lobular breast and
stomach cancers (Vos et al., 1997), and germline mutations
in E-cadherin have been found in families with a predispo-
sition to a form of diffuse gastric carcinoma (Guilford et
al., 1998). The role of E-cadherin in early stages implicates
it in the control of cell growth or proliferation. In this re-
gard, reexpression of E-cadherin has been found to slow
the growth rates of a few cell lines (Navarro et al., 1991;
Miyaki et al., 1995; St. Croix et al., 1998). Since 
 
 
 
-catenin
has been also implicated in cell growth control and apop-
tosis (Ahmed et al., 1998; He et al., 1998; Orford et al.,
1999; Tetsu and McCormick, 1999; Zhu and Watt, 1999), it
might be expected to play a role in regulating growth by
E-cadherin. However, an increase in cell adhesion result-
ing from expression of functional E-cadherin molecules
could also control cell growth properties by altering over-
all cytoskeletal and junctional organization, or by facilitat-
ing juxtacrine signaling via other receptor systems. For ex-
ample, junctional proteins such as discs large and scribbled
have effects on cell proliferation (Woods and Bryant,
1991; Wodarz, 2000), and VE-cadherin has been found to
facilitate signaling through VEGF receptors (Carmeliet et
al., 1999). Thus, there are multiple ways that the cadherin
could possibly mediate tumor suppression.
Therefore, we wished to determine the mechanism by
which E-cadherin acts as a tumor suppressor using a colo-
rectal cell line as a model system. This tumor cell type was
chosen to analyze the relationship between cell adhesion
and 
 
 
 
-catenin signaling since the 
 
 
 
-catenin signaling path-
way is often upregulated in colon cancers. In this study, we
asked whether the ability of E-cadherin to bind and antag-
onize the nuclear signaling activity of 
 
 
 
-catenin or mediate
cell–cell adhesion and close cell contact is most critical to
its tumor suppressor function. We expressed wild-type
E-cadherin or various E-cadherin chimeras lacking either
adhesive function or 
 
 
 
-catenin binding activity in a col-
orectal cell line expressing little or no endogenous E-cad-
herin. In vitro assays for cell growth and analysis of 
 
 
 
-cate-
nin/TCF signaling were used to assess tumor suppressor
and signaling activities of the various constructs.
 
Materials and Methods
 
Plasmids
 
Partial cDNA for human E-cadherin was provided by D. Rimm (Yale
University, New Haven, CT) and subcloned into the pcDNA3 mammalian
expression vector (Invitrogen). Sequence analysis revealed that the 3
 
 
 
 end
of the gene was missing after nucleotide 2644 (according to EMBL/Gen-
Bank/DDBJ under accession number L08599). This results in a truncation
of the last 35 amino acids of the E-cadherin cytoplasmic domain and, as a
result, does not contain the 
 
 
 
-catenin binding region, as defined by Stap-
pert and Kemler (1994). The COOH terminus of this truncation mutant
(E-cadherin 
 
 
 
 
 
 
 
-catenin) ends at amino acid 844 (NH
 
3
 
-ASLSSH); the
frameshift adds a single histidine residue before a stop codon is intro-
duced. The full-length human E-cadherin was reengineered using RNA
from human A431 cells and the RT-PCR method (Primer A, 5
 
 
 
-TGA-
CACCCGGGACAACGTTTATTA-3
 
 
 
, and Primer C, 5
 
 
 
-CTAGTCTA-
GACCCCTAGTGGTCCTCG-3
 
 
 
) to generate a 425-bp fragment encod-
ing the missing COOH-terminal residues. This fragment was sub-cloned
into the truncated hEcad-
 
 
 
 35/pcDNA3 vector to generate full-length
hEcad/pcDNA3. For the E-cadherin–
 
 
 
-catenin fusion construct that lacks
the 
 
 
 
-catenin binding domain in both E-cadherin and 
 
 
 
-catenin, cDNA
encoding the membrane proximal region of the cadherin cytoplasmic do-
main was amplified between nucleotides 1760 and 2530 using 5
 
 
 
 (5
 
 
 
-
TGAGCACGTGAAGAACAGCACGTACAC-3
 
 
 
) and 3
 
 
 
 (5
 
 
 
-CCCTG-
GCCATTTCCAATTTCATCGGGA-3
 
 
 
) oligonucleotide primers, and
the resultant 770-bp fragment was cloned into a 
 
Xenopus 
 
 
 
-catenin cDNA
such that amino acid 801 in E-cadherin was fused in frame with amino acid
201 in 
 
 
 
-catenin (E-cad-DEIGN/GHRDQ-
 
 
 
-catenin). This fusion region
was further subcloned into the E-cad/pcDNA3 plasmid to make the E-cad-
herin–
 
 
 
-catenin cDNA. For the IL2R/E-cadherin cytoplasmic chimera
construct, the cDNA encoding the IL2R-1 
 
 
 
 subunit was provided by Su-
 
1
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san LaFlamme (pCMV-IL2R-1; Albany Medical College, Albany, NY). A
PCR fragment encoding the entire cytoplasmic region of the cadherin was
obtained using the 5
 
 
 
 A and 3
 
 
 
 C primers described above and subcloned
into IL2R-1/pCMV expression vector. All constructs were verified by
DNA sequencing. The human N-cadherin cDNA was provided by J.
Hemperly (Becton Dickinson Technologies). The E-cadherin 
 
 
 
 p120
 
ctn
 
cDNA was provided by A. Reynolds (Vanderbilt University, Nashville,
TN) (Thoreson et al., 2000). The 
 
 
 
-catenin–engrailed repressor fusion
construct was provided by U. Mueller and Pierre McCrea (University of
Texas, Houston, TX) (Montross et al., 2000). The constitutively activating
LEF construct (LEF
 
 
 
N-
 
 
 
 CTA; where the COOH-terminal transactiva-
tion domain of 
 
 
 
 -catenin was fused to LEF
 
 
 
N) was provided by K. Vlem-
inckx (Vleminckx et al., 1999). The 
 
Xenopus
 
 TCF-3 cDNA was provided
by H. Clevers; dominant-negative TCF (NH
 
2
 
-terminal deletion of the 
 
 
 
-cat-
enin binding region of TCF-3) and activated TCF-3 (NH
 
2
 
-terminal 
 
 
 
-cate-
nin binding region of TCF-3 replaced with the potent transactivation do-
main, VP16) are described elsewhere (Vonica et al., 2000).
 
Cell Culture and Stable Transfections
 
The SW480 human colon carcinoma cell line was obtained from American
Type Culture Collection and grown in DME supplemented with 10%
FBS, 1% L-glutamine, 100 U/ml penicillin, and 100 
 
 
 
g/ml streptomycin
(GIBCO BRL). Cells were transfected with Lipofectamine reagent
(GIBCO BRL), and colonies were selected in G418 (800 
 
 
 
g/ml). Stable
clones were first isolated with cloning cylinders, expanded, and screened
for protein expression by Western analysis. Positives were then subjected
to one round of subcloning by limiting dilution and then examined by im-
munofluorescence to ensure homogeneous clonal expression. Three inde-
pendent clones were selected per cadherin construct based solely on
clonal expression characteristics.
 
Cell Growth Assays
 
Anchorage-independent Growth in Soft Agar. 
 
According to standard proto-
cols, 10
 
4
 
 cells from each cell line were suspended in 2.5 ml of 0.3% agarose
medium containing DME 
 
 
 
 5% FBS and layered onto a 2.5-ml bed of
0.6% agarose in a 35-mm dish with grids. Plates were incubated 
 
 
 
14 d,
and the number of colonies 
 
 
 
100 
 
 
 
m was counted.
 
Growth on Plastic Culture Dishes. 
 
2 
 
 
 
 10
 
4
 
 cells from each cell line were
seeded in triplicate on six-well plates and cultured in DME supplemented
with 2% FBS. At each time point, cells were trypsinized to single cell sus-
pension and counted on a Coulter counter set 
 
 
 
10-
 
 
 
m diameter.
 
Colony Formation Assays. 
 
For colony formation after transfection with
drug selection, an equivalent number of SW480 cells (10
 
6
 
–5 
 
 
 
 10
 
6
 
) were
transfected without DNA, 2 
 
 
 
g control or E-cadherin plasmid DNAs con-
ferring neomycin drug resistance (pcDNA3neo or E-cadherin pcDNA3-
neo), and 10–1000-fold dilutions of various LEF/TCF-expressing plasmids
that confer no drug resistance (pCS2
 
 
 
 vectors). The total amount of
pcDNA3 and pCS2 vectors was held constant for each transfection by the
addition of empty pCS2 vector. After transfection, cells were replated, se-
lected in G418-containing media for 
 
 
 
3 weeks, and the resultant colonies
were fixed and stained with crystal violet. Transfections were done in trip-
licate for each combination of plasmids. For colony formation of drug-
selected stables, to confirm that colony formation reflects the anchorage-
independent and -dependent growth properties of the stable cell lines
characterized in Fig. 2, 500 cells from each cadherin construct–expressing
stable cell line were seeded onto a 10-cm dish in DME supplemented with
10% FBS. After 
 
 
 
14 d, cells were fixed, stained, and quantified.
 
Adhesion Assay
 
Adhesion assays were performed as described essentially by Brieher et al.
(1996), with the exception that a human E-cadherin–Fc-recombinant fu-
sion protein was used as an adhesive substrate.
 
Glycoprotein Fractionation, Immunofluorescence, 
and SDS-PAGE/Western Analysis
 
Crude purification of glycoprotein-bound and -unbound fractions of 
 
 
 
-cat-
enin was performed as described essentially in Fagotto et al. (Fagotto et
al., 1996). In brief, SW480 stable cell lines were extracted in a non-ionic
detergent buffer (1% nonidet, 50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM
EDTA) and equal amounts of total protein (20 
 
 
 
g) were incubated for 1 h
with 50 
 
 
 
l (
 
 
 
300 
 
 
 
g concanavalin) concanavalin A (ConA)–Sepharose
(Sigma-Aldrich). ConA-bound proteins were washed, and equivalent pro-
portions of the ConA-bound and -unbound proteins were subjected to
standard SDS-PAGE and immunoblot analysis (Laemmli, 1970; Towbin et
al., 1979). For experiments where the levels of cadherin constructs, 
 
 
 
-cate-
nin, or c-myc proteins were determined, cells were extracted in boiling
RIPA buffer (same as above with addition of 2% SDS). All blots were in-
cubated with either the anti–E-cadherin mAb (HECD-1; Zymed Labora-
tories), anti–N-cadherin mAb (3B9; Zymed Laboratories), anti–c-myc
polyclonal antibody (C-19; Santa Cruz Biotechnology, Inc.), anti-myc
epitope mAb (9E10), anti-
 
 
 
-catenin (rabbit polyclonal; McCrea et al.,
1993), and HRP-conjugated anti–mouse and anti–rabbit secondary anti-
bodies (Bio-Rad Laboratories). Labeled proteins were visualized with
ECL (Amersham Pharmacia Biotech). To detect nuclear 
 
 
 
-catenin, cells
were fixed with methanol and processed according to standard immuno-
fluorescence protocols.
 
Recombinant Fusion Protein Binding Experiments
 
To evaluate cadherin- or TCF-binding capacity of 
 
 
 
-catenin in SW480
cells, a cell lysate (1% nonidet 40–containing buffer) or 100,000-
 
g
 
 deter-
gent-free supernatant (Reinacher-Schick and Gumbiner, 2001) was sub-
jected to consecutive affinity precipitations (30
 
 
 
 incubations 
 
 
 
 3) with a
glutathione 
 
S
 
-transferase (GST) fusion protein containing the cytoplasmic
domain of C-cadherin (Yap et al., 1998) or the 
 
 
 
-catenin binding region of
 
Xenopus
 
 TCF-3. 
 
 
 
-catenin that was not depleted by these incubations
was precipitated with TCA, and GST–cadherin or GST–TCF-bound and
-unbound fractions were subjected to SDS-PAGE analysis.
 
 
 
-Catenin/TCF Gene Reporter Assay
 
2.5–5 
 
 
 
 10
 
5
 
 cells from each stable cell line were seeded in triplicate and
transfected with 1 
 
 
 
g of the LEF/TCF luciferase reporter plasmid, TOP-
FLASH (gift of H. Clevers, University of Utrecht, Netherlands), and 1 
 
 
 
g
of a 
 
 
 
-galactosidase reporter gene to control for transfection efficiency.
After 36 h, luciferase activities were measured from cell lysates using a lu-
ciferase assay reagent (Promega). 
 
 
 
-Galactosidase activities were deter-
mined by standard methods (Promega). Results are expressed as light
units normalized to 
 
 -galactosidase activity.
Results
E-Cadherin Exhibits Growth Suppressor Activity in 
the SW480 Cell Line Via the Cytoplasmic Domain
The SW480 human colon carcinoma cell line expresses
low, or virtually undetectable, amounts of E-cadherin. It
also carries a mutation in the APC tumor suppressor gene
product, resulting in sustained upregulation of the  -cate-
nin/TCF signaling pathway (Korinek et al., 1997; Morin et
al., 1997). The ability of cells to exhibit anchorage-inde-
pendent growth is considered a hallmark of neoplastic
transformation. Therefore, we examined the capacity of
E-cadherin and the various constructs to inhibit growth in
soft agar, a commonly used assay for anchorage-indepen-
dent growth. Stable expression of a wild-type E-cadherin
was able to inhibit the growth of this cell line in three inde-
pendently derived clones (see Fig. 2, A and B). This
growth suppression occurs at physiological levels of cad-
herin expression since the levels of E-cadherin in these
clones were less than the levels detected in other colon-
derived cell lines (i.e., HT29 and HCT116; data not shown).
The role of E-cadherin in the suppression of cell invasive-
ness could not be evaluated because the SW480 cell line
does not exhibit significant invasive activity using in vitro
assays (de Both et al., 1999; data not shown).
Constructs were generated to evaluate the roles of adhe-
sive function or  -catenin binding in growth suppression.
Two E-cadherin constructs were used to restore intercellu-
lar adhesion without binding to  -catenin (Fig. 1): E-cad-
herin fused directly to  -catenin (E-cadherin– -catenin)The Journal of Cell Biology, Volume 153, 2001 1052
and an E-cadherin with a deletion of the  -catenin binding
region (E-cadherin    -catenin). The E-cadherin– -cate-
nin fusion links the membrane proximal region of the cad-
herin cytoplasmic domain directly to amino acid 201 of
 -catenin, deleting the  -catenin binding regions of both
proteins. A similar chimera was found to mediate strong
adhesion when expressed in fibroblasts (Nagafuchi et al.,
1994). Similarly, cadherin constructs that lack the  -cate-
nin binding region have been shown to exhibit basic adhe-
sive activity in several cell systems (Navarro et al., 1995;
Yap et al., 1998). For a protein that binds  -catenin but does
not mediate adhesion, the cytoplasmic domain of E-cad-
herin was fused to the extracellular domain of the interleu-
kin-2 receptor   subunit (IL2R). In fact, similar protein
constructs have been found to act as dominant-negative
inhibitors of adhesion (Kintner, 1992; Broders and Thiery,
1995; Lee and Gumbiner, 1995).
cDNAs encoding the various constructs in Fig. 1 were
transfected into the SW480 cell line, and cell clones were
selected on the basis of homogenous expression through-
out the population. Three independent clones were se-
lected for each construct to ensure that any observed ef-
fects were not due to phenotypic variability inherent to
genetically unstable human cancer cell lines. As stated
previously, the wild-type cadherin significantly inhibited
growth in soft agar (Fig. 2 A). This growth inhibitory activ-
ity maps largely to the cytoplasmic domain of the cad-
herin, since an IL2R/E-cadherin cytoplasmic domain chi-
mera exhibited the strongest inhibition, whereas little or
Figure 1. Schematic diagram of E-cadherin constructs used in
this study. Wild-type E-cadherin (top) is shown. The next two
constructs (middle) were designed to mediate adhesion without
interacting with  -catenin: E-cadherin– -catenin fusion construct
joins the extracellular and membrane proximal (p120ctn binding)
region of E-cadherin directly with  -catenin; the E-cadherin    -cat-
enin construct is truncated before the  -catenin binding region.
The E-cadherin   p120ctn construct contains 3 Gly   Ala point
mutations and therefore cannot interact with p120ctn. The IL2R/
E-cadherin cytoplasmic chimera fuses the extracellular and trans-
membrane domains of the interleukin-2 receptor   subunit to the
cytoplasmic domain of E-cadherin. This construct can bind  -cat-
enin but cannot engage in homophilic adhesive activity.
Figure 2. Growth properties of cadherin construct–expressing
cell lines. Three independent clones per construct were analyzed.
(A) Anchorage-independent growth. An equivalent number of
cells from each stable cell line was seeded into soft agar, and colo-
nies   100   m diameter were counted after  14 d in culture.
Three independent clones per construct (columns 1, 2, and 3)
were characterized (  SEM). (B) Growth properties of cell clones
on plastic. Each data point represents the mean from the three in-
dependent cell lines. (C and D) Western blot analysis and relative
expression levels of cadherin construct–expressing cell lines after
immunoblotting with an mAb to the extracellular domain of E-cad-Gottardi et al. Mechanism for E-Cadherin Tumor Suppression 1053
no inhibition was observed for the cadherin constructs de-
signed to rescue adhesion, E-cadherin– -catenin fusion,
and the E-cadherin    -catenin. Similar results were ob-
served when standard rates of log phase growth were mea-
sured for each cell line (Fig. 2 B). The differences in
growth inhibition do not result from differences in levels
of protein expression, as the IL2R-cytoplasmic construct is
less well-expressed than either wild-type E-cadherin or the
E-cadherin      -catenin construct and about equally as
well-expressed as the E-cadherin– -catenin fusion (Fig. 2,
C and D). Therefore, growth inhibition results primarily
from the presence of the cadherin cytoplasmic domain but
little if any from the adhesive function of E-cadherin.
The cytoplasmic domain of the cadherin can bind di-
rectly to p120ctn as well as  -catenin, and either protein
could play a role in growth suppression. To determine
whether p120ctn binding was involved in cadherin-medi-
ated growth suppression, stable cell lines expressing mutant
E-cadherin incapable of binding p120ctn were generated
(Thoreson et al., 2000; Fig. 1). This E-cadherin  -p120ctn
construct was still able to inhibit SW480 growth (Fig. 2 E).
Together with the observation that deletion of the  -cate-
nin binding region caused a loss of growth inhibitory activ-
ity of the cadherin (Fig. 2, A and B), these data suggest
that   -catenin binding, but not p120ctn binding, is most
critical for the growth suppressor activity of E-cadherin in
SW480 cells. Furthermore, this growth-suppressing activ-
ity is not unique to E-cadherin since N-cadherin, which binds
 -catenin strongly, also manifested this activity (Fig. 2 E).
The E-cadherin– -catenin fusion chimera and E-cad-
herin    -catenin were expected to mediate effective ho-
mophilic adhesion without being able to bind  -catenin.
However, we wished to confirm that these proteins actu-
ally mediate adhesion in SW480 cells, especially since their
levels were somewhat lower than the wild-type molecule
(Fig. 2 C). We therefore measured relative adhesive activi-
ties of cells expressing these constructs using a flow assay
to measure the strength of cell attachment to purified solu-
ble E-cadherin ectodomain as described for C-cadherin
(Brieher et al., 1996). All of the cadherin-expressing cell
lines adhered more strongly than the mock-transfected
E-cadherin–negative parental SW480 cells (Fig. 3). The
E-cadherin– -catenin fusion construct exhibited adhesive
activity well over background and almost as good as the
wild-type cadherin, even though it is less well expressed
(Fig. 2 C). By contrast, the E-cadherin    -catenin–express-
ing cell line exhibited even stronger adhesive activity than
the wild-type cadherin–expressing cells, despite the fact
that it is less well expressed (approximately threefold; Fig.
2 C). This finding is not really surprising in light of previ-
ous experiments showing that similar mutant C-cadherin
and VE-cadherin constructs have adhesive activities com-
parable to wild-type molecules when expressed in CHO
cells, presumably due in some way to p120ctn binding (Na-
varro et al., 1995; Yap et al., 1998). Why this mutant cad-
herin has even higher adhesive activity than the wild type
in SW480 cells is not yet clear. Nevertheless, since these
two constructs failed to inhibit SW480 growth compared
with the wild-type cadherin (Fig. 2, A and B), the adhesion
activity of E-cadherin does not appear to be sufficient to
mediate growth inhibition.
Growth-suppressing Activity of E-Cadherin Is Mediated 
through a Reduction in  -Catenin/TCF Signaling
The observation that the cytoplasmic domain of E-cad-
herin, and in particular the  -catenin binding region, con-
tains the information to inhibit SW480 cell growth suggests
that growth inhibition may be mediated through a  -cat-
enin–dependent signaling pathway. We therefore asked
whether expression of the different cadherin constructs
could influence  -catenin signaling activity at target genes.
A  -catenin/TCF–dependent reporter gene assay (TOP-
FLASH; Korinek et al., 1997) revealed that each of the
wild-type E-cadherin and IL2R/E-cadherin cytoplasmic
domain–expressing cell lines exhibit reduced target gene
activation, but no consistent inhibition was observed for
the other cell lines (Fig. 4 A). Furthermore, expression of
an endogenous candidate target gene for the  -catenin/
TCF signaling pathway in colon cells, the c-myc proto-onco-
gene (He et al., 1998), is reduced in the cadherin and
IL2R/E-cadherin cytoplasmic domain–expressing cell lines
(Fig. 4 B).
To determine whether upregulation of the  -catenin sig-
naling pathway contributes to the growth of SW480 cells,
herin (HECD-1) (C), or with an antibody that recognizes the cy-
toplasmic domain of the cadherin (D) (Pep1 polyclonal antibody;
Choi and Gumbiner, 1989). (E) Anchorage-independent growth
properties and Western analysis of E-cadherin   p120ctn and
N-cadherin. Mock-transfected (Control), E-cadherin   p120ctn,
and N-cadherin–expressing cell lines were seeded into soft agar,
and the number of colonies was counted after  15 d. Western
analysis of E-cadherin   p120ctn and N-cadherin–expressing cell
lines is shown.
Figure 3. Adhesive properties of cadherin-expressing cell lines
using a laminar flow cell attachment assay. Mock-transfected
control SW480 cells and SW480 cells expressed wild-type E-cad-
herin, E-cadherin    -catenin, or an E-cadherin– -catenin fu-
sion, remaining attached to glass capillary tubes coated with the
extracellular domain of human E-cadherin after increasing flow
rates (ml/min). Each curve represents adhesive activity of a given
construct-expressing cell line. Adhesive activity shown above was
completely calcium dependent (data not shown).The Journal of Cell Biology, Volume 153, 2001 1054
we examined whether cell growth is affected by inhibition
of  -catenin nuclear signaling at a downstream step. Ei-
ther of two constructs known to inhibit  -catenin signaling
at the level of target genes,  -catenin fused to the en-
grailed repressor domain, and a dominant-negative form
of TCF were expressed in control SW480 cells (Molenaar
et al., 1996; Montross et al., 2000). Stable expression of
the  -catenin/engrailed chimera significantly inhibited an-
chorage-independent growth of SW480 cells compared
with mock-transfected cells (Fig. 5 A). We failed to gener-
ate stable transfectants with readily detectable levels of
the dominant-negative TCF and, therefore, turned to a
colony-forming assay to measure growth potential. This
assay appears to be a valid measure of anchorage-indepen-
dent growth for SW480 cell lines because it mirrored the
results of the soft agar assay (Fig. 5 B). Using this assay, a
dominant-negative form of TCF potently inhibited the
number of colonies formed compared with control-trans-
fected cells (Fig. 5 C). This reduction in colony number is
not due to simple toxicity from the TCF vector, as trans-
fection with the  -catenin cDNA in the same vector
caused no reduction in colony number (data not shown).
Thus, specific inhibition of  -catenin nuclear signaling ac-
tivity reduces SW480 cell growth, indicating that this path-
way contributes to the high growth rate of these cells.
To determine whether the observed E-cadherin–medi-
ated growth inhibition occurred through a reduction in the
activity of a  -catenin/TCF signaling pathway, we asked
whether the E-cadherin–mediated growth inhibition could
be rescued at a downstream step with constitutively active
forms of LEF or TCF. Transfection with E-cadherin–express-
ing plasmids alone reduced the number of drug-resistant
colonies formed in the colony-forming assay, as expected
(Fig. 6). Inhibition of colony formation by E-cadherin was
reversed by cotransfecting with low amounts of plasmid en-
coding constitutively active forms of LEF or TCF. Specific-
ity of the rescue for constitutively activated TCF was dem-
onstrated by the lack of effect of either the wild-type or a
dominant-negative form of TCF (Fig. 6 B). Titration of the
LEF or TCF-expressing plasmids was required for optimal
rescue effect, presumably because high levels of these tran-
scription factors have inhibitory activity due to squelching
or sequestration of transcription machinery components.
The rescue of E-cadherin–mediated growth inhibition by
Figure 4. Activities of  -catenin/TCF target genes. E-cadherin
or E-cadherin construct–expressing SW480 cell lines. (A)  -cate-
nin/TCF-dependent reporter gene assay. Individual cell lines
were transiently transfected with the  -catenin/TCF–dependent
luciferase reporter gene (TOPFLASH) and a  -galactosidase re-
porter plasmid to control for transfection efficiency. Negligible
activity was observed when the TCF binding sites were mutated
(FOPFLASH; not shown). (B and C) Expression of product of
endogenous  -catenin/TCF target gene, c-myc: control and cad-
herin construct–expressing cell lines were analyzed by SDS-
PAGE and immunoblotting with  -catenin and c-myc specific
antibodies. Individual cell lines were examined in B; cell lines
were pooled in C.
Figure 5. Inhibition of  -cat-
enin/TCF gene activation sup-
presses SW480 cell growth.
(A) Anchorage-independent
growth of  -catenin/engrailed
repressor–expressing cell lines.
(B) Colony-forming assay re-
flects the growth properties
of stably transfected cad-
herin construct–expressing
cell lines. The stable cell lines
characterized for growth in
soft agar and growth on plas-
tic in Fig. 2 were assessed for
their ability to inhibit colony
formation when plated un-
der dilute conditions (500
cells plated per dish). Each
bar represents the mean of
three independent cell lines
evaluated for each cadherin
construct. (C) Dominant-neg-
ative TCF inhibits growth of
SW480 cells, as assessed with
the colony-forming assay.
Cells were transfected with a
neomycin drug resistance
plasmid (control [neo]  )
with or without increasing
amounts (0.002, 0.02, and
0.2  g) of plasmid expressing a dominant negative (dn TCF). Re-
sults are from triplicate transfections ( SEM).Gottardi et al. Mechanism for E-Cadherin Tumor Suppression 1055
constitutively active forms of LEF or TCF provides com-
pelling evidence that E-cadherin inhibits cell growth through
a reduction in  -catenin/TCF signaling.
The Cadherin Cytoplasmic Domain Mediates 
Growth Inhibition Without Depleting 
Cytosolic or Nuclear  -Catenin
Previous studies with Xenopus embryos have shown that
cadherins can inhibit  -catenin signaling activity through
direct binding and recruitment to the plasma membrane,
resulting in the depletion of the cytosolic and nuclear sig-
naling pools of  -catenin (Heasman et al., 1994; Fagotto et
al., 1996). Since both wild-type E-cadherin and the cyto-
plasmic domain of E-cadherin can interact with  -catenin,
we wished to determine whether the reduction in  -cate-
nin/TCF signaling and growth inhibition was due to seques-
tering  -catenin from the nuclear signaling pool. The sub-
cellular localization of  -catenin was determined by both
cell fractionation and immunofluorescence microscopy
techniques. The lectin ConA can be used to quantitatively
separate the cadherin-bound pool of  -catenin from the
unbound pool (see Materials and Methods; Fagotto et al.,
1996). Although expression of wild-type cadherin or the
IL2R/E-cadherin cytoplasmic chimera increased the amount
of  -catenin recruited to the glycoprotein-associated frac-
tion, the extremely large soluble pool of  -catenin in these
cells is not significantly depleted (Fig. 7 A). Identical re-
sults were observed when cytosolic and membrane frac-
tions were separated using a detergent-free/hypotonic lysis
method (data not shown). The total levels of  -catenin
were largely unaltered (Fig. 7 B), and no obvious differ-
ence in the nuclear accumulation of  -catenin was detected
in any of the cadherin construct–expressing stable cell lines
(Fig. 7 C). Similarly, no significant changes in the levels, se-
questration, or nuclear localization of plakoglobin, p120ctn,
and  -catenin were detected between the various cell lines
(data not shown). Thus, expression of E-cadherin or IL2R/
E-cadherin did not significantly deplete the large cytosolic/
nuclear pools of  -catenin in the SW480 cells, even though
they inhibited  -catenin nuclear signaling.
Inhibition of  -catenin signaling without reducing cytoso-
lic levels may appear at first glance to be inconsistent with
the known mechanism of regulating  -catenin nuclear sig-
naling (i.e., via reduction of its cytosolic levels). However,
one possible explanation is that only a subfraction of the
large cytosolic pool of  -catenin in SW480 cells is transcrip-
tionally competent, and this competent active signaling
pool is preferentially bound and depleted by E-cadherin in
the cell. To determine whether SW480 cells contain distinct
pools of  -catenin that differ in their competence to inter-
act with E-cadherin, a cytosolic fraction (detergent-free
100,000 g supernatant) from SW480 cells was subjected to
sequential affinity precipitations with a cadherin cytoplas-
mic domain–GST fusion protein. Only a very small amount
of the cytosolic  -catenin could be precipitated by the cad-
herin–GST fusion protein (Fig. 8 A), showing that a sizable
fraction of  -catenin in SW480 cells is refractory to cad-
herin binding. Similarly, using sequential precipitations
with a TCF–GST fusion protein, only a small amount of the
cytosolic  -catenin was capable of binding TCF (Fig. 8 B),
suggesting that SW480 cells contain a large pool of tran-
scriptionally incompetent or inactive  -catenin. The cad-
herin– and TCF–GST fusion proteins are able to bind  -cat-
enin effectively since they could affinity precipitate  -catenin
extracted from SW480 cells under more disruptive deter-
gent lysis conditions (Fig. 8, C and D). The cadherin seems
to be able to bind all of the  -catenin that is competent to
interact with TCF because the cadherin depleted pool can
no longer interact with TCF–GST (Fig. 8 C). Furthermore,
the TCF–GST-depleted pool of  -catenin is not able to
bind to the cadherin–GST protein (Fig. 8 D). Therefore,
the cadherin-titratable pool of  -catenin appears to be the
same as the transcriptionally competent active signaling
pool that interacts with TCF. Moreover, the existence of a
large cytosolic pool of  -catenin in SW480 cells that is re-
fractory to both cadherin and TCF binding explains, at least
in part, how E-cadherin expression can bind and inhibit the
active signaling pool of  -catenin without significantly re-
ducing its overall levels in the cytosol and nucleus.
Figure 6. Constitutively activated forms of LEF and TCF rescue
cadherin-mediated growth inhibition of SW480 cells. (A) Colony
formation assay after transfection with E-cadherin or E-cadherin
plus activated LEF ( -catenin COOH-terminal transactivation
domain fused directly to LEF). Control plasmid (pcDNA3neo),
E-cadherin/pcDNA3neo plasmid (E-cadherin [neo]) or activated
LEF (0.0001–1.0  g). (B) Colony–forming assay after transfec-
tion with E-cadherin or E-cadherin plus activated TCF (VP16
transactivation domain fused to TCF-3), and wild-type TCF (wt-
TCF) or dominant-negative TCF (dnTCF) as controls. TCF-
encoding plasmids were titrated for optimal effect (0.001–0.1  g).
Bars represent mean number of colonies from triplicate transfec-
tions ( SEM).The Journal of Cell Biology, Volume 153, 2001 1056
Discussion
We have examined the mechanism by which E-cadherin
expression mediates tumor suppression in light of two
known aspects of cadherin function: cell adhesion and the
ability to bind  -catenin and influence its signaling and
transcriptional activity in the nucleus. We find that E-cad-
herin suppresses the growth of the SW480 human colon
carcinoma cell line and that this activity is mediated
through an adhesion-independent,  -catenin/TCF–depen-
dent signaling mechanism. Both wild-type E-cadherin and
an IL2R/E-cadherin chimera that retains the cadherin cy-
toplasmic domain but lacks the extracellular homophilic
adhesive domain potently inhibited anchorage-indepen-
dent and log phase cell growth. Moreover, cadherin con-
structs that exhibit adhesive activity when expressed in
SW480 cells, but do not bind  -catenin, failed to inhibit
cell growth (e.g., the E-cadherin– -catenin chimera and
the E-cadherin    -catenin mutant). Thus, the homophilic
adhesive activity of E-cadherin is neither necessary nor
sufficient to mediate strong growth inhibition in the
SW480 cell line. Furthermore, using several different crite-
ria, we show that cadherin-mediated growth inhibition acts
through a  -catenin/TCF–dependent signaling mecha-
nism. A construct that lacks the  -catenin binding region
did not suppress growth. Growth inhibition of the cad-
herin correlated with a reduction in  -catenin transcrip-
tional activity, as assessed with a  -catenin/TCF–respon-
sive reporter assay. Moreover,  -catenin signaling clearly
plays a physiological role in the growth properties of
Figure 7. Levels and subcellular distribution of  -catenin are
not significantly altered in cadherin construct–expressing SW480
cell lines. (A) Fractionation of  -catenin into cadherin-associated
and soluble pools using the lectin ConA. Detergent lysates were
incubated with ConA-Sepharose (amount predetermined to de-
plete all of the cadherin) and equivalent proportions of the
ConA-bound (B) and -unbound (U) fractions were analyzed by
SDS-PAGE and immunoblotting. Two cell lines per constructs
were analyzed. (B) Total levels of  -catenin: Western blot of SDS
lysates of individual cell lines. (C) Indirect immunofluorescence
microscopy of cadherin-constructs (CY-3) and  -catenin (FITC)
in control and cadherin construct–expressing stable cell lines.
Figure 8. SW480 cells contain a large pool of  -catenin that does
not interact with either cadherins or TCF. (A) Only a small frac-
tion of cytosolic  –catenin is competent to interact with the cad-
herin cytoplasmic domain in vitro. Sequential depletion of  -cat-
enin (1st, 2nd, and 3rd) from a detergent-free 100,000-g
supernatant fraction of SW480 cells with cadherin–GST (cad-
GST), and TCA precipitation of the unbound fraction. (B) Only a
small fraction of cytosolic  -catenin is competent to interact with
the TCF in vitro. Sequential depletion of  -catenin from the
100,000-g supernatant fraction of SW480 cells with TCF–GST, and
TCA precipitation of the unbound fraction. (C) Cadherin-unbind-
able pool of  -catenin does not interact with TCF. Sequential de-
pletion of  -catenin from an SW480 cell detergent lysate with cad-
GST (1st, 2nd, and 3rd), and final depleted fraction subject to
either TCA precipitation (unbound) or binding to TCF–GST.
(D) TCF-unbindable pool of  -catenin does not interact with the
cadherin cytoplasmic domain. Sequential depletion of  -catenin
from an SW480 cell detergent lysate with TCF–GST (1st, 2nd,
3rd), and final depleted fraction subject to either TCA precipita-
tion (unbound) or binding to cad-GST. Samples were separated
by SDS-PAGE, and  -catenin was detected by immunoblotting.Gottardi et al. Mechanism for E-Cadherin Tumor Suppression 1057
SW480 cells, since direct inhibition of  -catenin target
genes with either a dominant-negative form of TCF, or a
 -catenin-engrailed repressor chimera, inhibited cell growth.
E-cadherin–mediated growth inhibition was rescued with
constitutively active forms of LEF or TCF that bypass the
requirement for an upstream  -catenin signaling activity.
Together, these results argue that the growth suppressor
activity of E-cadherin in SW480 colorectal tumor cells is
mediated through inhibiting the expression of  -catenin/
TCF–dependent target genes.
A few previous studies have found that cadherin expres-
sion can lead to inhibition of cell growth (Miyaki et al.,
1995; Hermiston et al., 1996; St. Croix et al., 1998). How-
ever, it had never been determined whether the effect on
growth was mediated by the cadherin directly or indirectly
through the establishment of close cell contacts, which in-
variably promote the formation of other junctional com-
plexes (e.g., tight junctions or gap junctions) and/or juxta-
crine signaling molecules with potentially independent
growth suppressing functions. For example, cadherins
have been shown to stimulate gap junction formation
(Musil et al., 1990), and VE-cadherin has been found to
regulate signaling through the VEGF receptor (Carmeliet
et al., 1999), which could occur by a juxtacrine mechanism.
Our finding that the growth inhibition of the cadherin is
attributed to the cytoplasmic domain, but not to cell adhe-
sion, demonstrates that the E-cadherin protein can di-
rectly transduce a growth inhibitory signal.
E-cadherin inhibits  -catenin/TCF signaling and SW480
tumor cell growth without noticeable changes in cytosolic/
nuclear levels of  -catenin protein, the major mechanism
thought to control  -catenin signaling (Polakis, 1999).
However, several studies have shown that  -catenin signal-
ing can be regulated, to some extent, independent of levels
or stabilization (Young et al., 1998; Nelson and Gumbiner,
1999; Guger and Gumbiner, 2000). One possible interpre-
tation, therefore, is that a large fraction of the  -catenin in
this cell line may not be active in nuclear signaling and that
sequestration of a minor active pool of  -catenin by E-cad-
herin could have significant effects on  -catenin signaling.
We show that there are two distinct pools of  -catenin in
SW480 cells, a pool that is competent to bind the cadherin
and TCF, and a pool that binds neither. Thus, E-cadherin
may be able to selectively sequester the transcriptionally
competent pool of  -catenin without depleting overall cy-
tosolic/nuclear levels of  -catenin. The biochemical basis
of these two pools of  -catenin is not yet clear, but obvious
candidates are phosphorylation or other types of modifica-
tions and/or binding proteins. For example, phosphoryla-
tion of a single tyrosine residue in  -catenin has been
shown to alter cadherin binding (Roura et al., 1999), and
two inhibitors of  -catenin signaling have been identified:
a small nuclear/cytoplasmic–localizing polypeptide, ICAT,
and a 120-kD nuclear protein, duplin (Sakamoto et al.,
2000; Tago et al., 2000). Using two-dimensional electro-
phoresis or gel filtration analysis, we have not yet been
able to distinguish these two distinct pools of  -catenin,
but further work may reveal molecular differences.
Our findings demonstrate that one important mecha-
nism by which E-cadherin mediates tumor suppression,
and in particular growth suppression, is through an inhibi-
tion of  -catenin signaling. Since the SW480 colorectal
cells used in this study express mutant APC, and therefore
significantly upregulate  -catenin signaling, these conclu-
sions may be particularly relevant for tumors in which
 -catenin signaling is implicated in cell transformation.
Thus, these findings provide evidence that the same tumor
cell can use two different mechanisms for negatively regu-
lating   -catenin signaling: the APC/glycogen synthase
kinase-3/axin–dependent destruction pathway and a cad-
herin-dependent pathway. Whether this adhesion-inde-
pendent mechanism also explains E-cadherin tumor sup-
pressor activity in cells that have not significantly
upregulated the  -catenin signaling pathway is not known
and will require further investigation.
In other tumor cell types, or different stages of the same
tumor type, it is possible that different mechanisms may
account for the tumor suppressor activity of E-cadherin.
The fact that E-cadherin has been implicated in both early
and late stages of tumor progression and has both growth
suppressor and invasion suppressor activities raises the
possibility of more than one mechanism. The role of E-cad-
herin in adhesion and epithelial junction formation may be
more important for later stages of tumor progression and
invasion. For example, adhesion-blocking E-cadherin anti-
bodies increase the invasive behavior of cells (Behrens et
al., 1989), and expression of the cadherin cytoplasmic do-
main, which is a dominant-negative for adhesion, actually
promotes the adenoma-to-carcinoma transition in a pan-
creatic tumor model (Perl et al., 1998). Furthermore, E-cad-
herin and APC loss-of-function mutations tend to be asso-
ciated with different cancer types (e.g., E-cadherin with
breast, gastric, and prostate cancers; the APC pathway
with colon, hepatic, and melanoma cancers). Therefore, it
will also be important to determine how E-cadherin func-
tions as either an invasion or tumor suppressor in other
types of tumors, especially those that are not known to re-
sult from mutations in APC or  -catenin.
These findings also have broad implications for biologi-
cal processes beyond tumorigenesis. Overexpression of
cadherins in early Xenopus and Drosophila embryos has
been found to antagonize  -catenin signaling. However,
the relevance of these experimental perturbations to nor-
mal development has been uncertain. In this tumor sup-
pressor model, normal levels of E-cadherin expression can
regulate cell growth through  -catenin signaling, suggest-
ing that there is a physiological relationship between cad-
herin expression (and/or function) and the  -catenin sig-
naling pathway. Moreover, unlike the case of cadherin
overexpression in Xenopus, the regulation of  -catenin
signaling in tumor cells is not simply due to overall
changes in cytosolic/nuclear levels, but rather to changes
in subpools of  -catenin. Indeed, it would not be surpris-
ing if the physiological relationship between the two func-
tions of  -catenin is not simply one of competition, but
rather a more complex mechanism subject to additional
layers of regulation. It will be interesting to determine
whether the interactions between cadherins and  -catenin
signaling are similarly regulated in developing tissues.
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